Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.48842 | 19 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.47958 | 20 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.48062 | 20 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.43731 | 21 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.91677 | 42 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.51211 | 19 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.49076 | 19 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.45108 | 20 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.46616 | 21 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.47097 | 20 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.45645 | 20 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.44762 | 20 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.46615 | 20 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.47054 | 20 |